58 twelve investment group is a leading investment management company founded in 2012 and headquartered in Shanghai, China. With its unique vision and business model, 58 twelve has grown rapidly to become an influential player in China’s asset management industry, managing assets of over 10 billion RMB. The group is best known for its four subcompanies focusing on frontier technologies – 58VC, 58Dao, 58AIGO and 58Bio, covering hot investment areas like blockchain, metaverse, artificial intelligence and biotechnology. By leveraging emerging technologies, 58 twelve aims to create sustainable value for investors.
58VC – Focused on blockchain technology investment
As one of the earliest institutional investors in the blockchain industry, 58VC has invested in many quality blockchain projects and cultivated multiple unicorn companies. It made early investments into major crypto exchanges like Binance and established cryptofunds like Bixin. 58VC is optimistic about the long-term potential of blockchain technology and its ability to reshape the global financial infrastructure. The subcompany manages crypto assets through index funds while making equity investments in promising startups.
58Dao – Exploring opportunities in the metaverse economy
58Dao specializes in metaverse investment. It aims to empower the builders of metaverse ecology and contribute to the formation of future virtual worlds. 58Dao has invested in many rising metaverse projects, covering areas like virtual social networking, digital real estate, NFT trading platforms, virtual concerts and augmented reality. With the metaverse gaining more attention globally, 58Dao is well-positioned to capitalize on new opportunities in this futuristic segment.
58AIGO – Focused on developing leading artificial intelligence technologies
58AIGO focuses on cutting-edge artificial intelligence technologies that can enhance productivity and decision-making. It has built a specialized AI lab for developing core algorithms and applications. At the same time, 58AIGO makes equity investments in AI startups with innovative business models and helps them with resources to accelerate growth. Its vision is to make AI more accessible and drive intelligent transformation across various industries.
58Bio – Investing in biotechnology breakthroughs
As a healthcare-focused investment firm, 58Bio places strategic bets on biotechnology companies with revolutionary technologies or treatments. It has invested in genetic testing, gene editing, immunotherapy, regenerative medicine, diagnostic devices and other biotech areas. 58Bio also co-establishes funds with pharmaceutical companies to finance clinical trials and new drug R&D. It aims to support innovation in biotech and generate good investment returns.
In summary, 58 twelve investment group manages over 10 billion RMB of assets across four subcompanies – 58VC, 58Dao, 58AIGO and 58Bio, focusing on frontier tech areas like blockchain, metaverse, AI and biotech. By leveraging emerging technologies, 58 twelve creates value for investors while contributing to technological progress.